Vaklavas et al. 2019 (PRJNA523167)

General Details

Title ribosome profiling of cell line models of human breast cancer
Organism
Number of Samples 47
Release Date 2019/02/19 00:00
Sequencing Types
Protocol Details

Study Links

Repository Details

SRA SRP186252
ENA SRP186252
GEO GSE126736
BioProject PRJNA523167

Publication

Title
Authors Vaklavas C,Blume SW,Grizzle WE
Journal Translational oncology
Publication Date 2020 Feb
Abstract Gene expression is extensively and dynamically modulated at the level of translation. How cancer cells prioritize the translation of certain mRNAs over others from a pool of competing mRNAs remains an open question. Here, we analyze translation in cell line models of breast cancer and normal mammary tissue by ribosome profiling. We identify key recurrent themes of oncogenic translation: higher ribosome occupancy, greater variance of translational efficiencies, and preferential translation of transcriptional regulators and signaling proteins in malignant cells as compared with their nonmalignant counterpart. We survey for candidate RNA interacting proteins that could associate with the 5'untranslated regions of the transcripts preferentially translated in breast tumour cells. We identify SRSF1, a prototypic splicing factor, to have a pervasive direct and indirect impact on translation. In a representative estrogen receptor-positive and estrogen receptor-negative cell line, we find that protein synthesis relies heavily on SRSF1. SRSF1 is predominantly intranuclear. Under certain conditions, SRSF1 translocates from the nucleus to the cytoplasm where it associates with MYC and CDK1 mRNAs and upregulates their internal ribosome entry site-mediated translation. Our results point to a synergy between splicing and translation and unveil how certain RNA-binding proteins modulate the translational landscape in breast cancer. Copyright © 2019 The Authors. Published by Elsevier Inc. All rights reserved.
PMC PMC6948383
PMID 31911279
DOI
Run Accession Study Accession Scientific Name Cell Line Library Type Treatment GWIPS-viz Trips-Viz Reads BAM BigWig (F) BigWig (R)
SRR8590754 PRJNA523167 Homo sapiens Human mammary epithelial cells (HMECs) Ribo-Seq Cycloheximide
SRR8590755 PRJNA523167 Homo sapiens Human mammary epithelial cells (HMECs) Ribo-Seq Cycloheximide
SRR8590756 PRJNA523167 Homo sapiens Human mammary epithelial cells (HMECs) Ribo-Seq Cycloheximide
SRR8590757 PRJNA523167 Homo sapiens Human mammary epithelial cells (HMECs) Ribo-Seq Cycloheximide
SRR8590758 PRJNA523167 Homo sapiens Human mammary epithelial cells (HMECs) Ribo-Seq Cycloheximide
SRR8590759 PRJNA523167 Homo sapiens Human mammary epithelial cells (HMECs) Ribo-Seq Cycloheximide
SRR8590760 PRJNA523167 Homo sapiens MCF10A Ribo-Seq
SRR8590761 PRJNA523167 Homo sapiens MCF10A Ribo-Seq
SRR8590764 PRJNA523167 Homo sapiens T47D Ribo-Seq
SRR8590765 PRJNA523167 Homo sapiens T47D Ribo-Seq
SRR8590766 PRJNA523167 Homo sapiens T47D Ribo-Seq Cycloheximide
SRR8590767 PRJNA523167 Homo sapiens T47D Ribo-Seq Cycloheximide
SRR8590768 PRJNA523167 Homo sapiens MCF10A Ribo-Seq Cycloheximide
SRR8590769 PRJNA523167 Homo sapiens MCF10A Ribo-Seq Cycloheximide
SRR8590772 PRJNA523167 Homo sapiens SUM159 Ribo-Seq
SRR8590773 PRJNA523167 Homo sapiens SUM159 Ribo-Seq
SRR8590774 PRJNA523167 Homo sapiens SUM159 Ribo-Seq
SRR8590775 PRJNA523167 Homo sapiens SUM159 Ribo-Seq
SRR8590778 PRJNA523167 Homo sapiens SUM159 Ribo-Seq Cycloheximide
SRR8590779 PRJNA523167 Homo sapiens SUM159 Ribo-Seq Cycloheximide
SRR8590780 PRJNA523167 Homo sapiens MDA Ribo-Seq Cycloheximide
SRR8590781 PRJNA523167 Homo sapiens MDA Ribo-Seq Cycloheximide
SRR8590782 PRJNA523167 Homo sapiens MDA Ribo-Seq Cycloheximide
SRR8590783 PRJNA523167 Homo sapiens MDA Ribo-Seq Cycloheximide
SRR8590784 PRJNA523167 Homo sapiens T47D Ribo-Seq
SRR8590785 PRJNA523167 Homo sapiens T47D Ribo-Seq
SRR8590786 PRJNA523167 Homo sapiens T47D Ribo-Seq
SRR8590790 PRJNA523167 Homo sapiens MCF10A Ribo-Seq Cycloheximide
SRR8590791 PRJNA523167 Homo sapiens MCF10A Ribo-Seq Cycloheximide
SRR8590794 PRJNA523167 Homo sapiens T47D Ribo-Seq Cycloheximide
SRR8590795 PRJNA523167 Homo sapiens T47D Ribo-Seq Cycloheximide
SRR8590796 PRJNA523167 Homo sapiens T47D Ribo-Seq Cycloheximide
SRR8590797 PRJNA523167 Homo sapiens T47D Ribo-Seq Cycloheximide
SRR8590798 PRJNA523167 Homo sapiens SUM159 Ribo-Seq Cycloheximide
SRR8590799 PRJNA523167 Homo sapiens SUM159 Ribo-Seq Cycloheximide
SRR8590800 PRJNA523167 Homo sapiens SUM159 Ribo-Seq Cycloheximide
SRR8590801 PRJNA523167 Homo sapiens SUM159 Ribo-Seq Cycloheximide
SRR8590802 PRJNA523167 Homo sapiens SUM159 Ribo-Seq Cycloheximide
SRR8590803 PRJNA523167 Homo sapiens SUM159 Ribo-Seq
SRR8590804 PRJNA523167 Homo sapiens SUM159 Ribo-Seq
SRR8590805 PRJNA523167 Homo sapiens SUM159 Ribo-Seq
SRR8590810 PRJNA523167 Homo sapiens MDA Ribo-Seq
SRR8590811 PRJNA523167 Homo sapiens MDA Ribo-Seq
SRR8590812 PRJNA523167 Homo sapiens MDA Ribo-Seq Cycloheximide
SRR8590813 PRJNA523167 Homo sapiens MDA Ribo-Seq Cycloheximide
SRR8590814 PRJNA523167 Homo sapiens MDA Ribo-Seq
SRR8590815 PRJNA523167 Homo sapiens MDA Ribo-Seq
Run Accession Study Accession Scientific Name Cell Line Library Type Treatment GWIPS-viz Trips-Viz Reads BAM BigWig (F) BigWig (R)

ⓘ For more Information on the columns shown here see: About